๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial

โœ Scribed by Stewart A. Factor; Joseph H. Friedman; Margaret C. Lannon; David Oakes; Keith Bourgeois

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
33 KB
Volume
16
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clozapine replacement by quetiapine for
Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
โœ Hubert H. Fernandez; Margaret C. Lannon; Joseph H. Friedman; Bruce P. Abbott ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB ๐Ÿ‘ 1 views

Cases of delayed or acute posttraumatic, therapy-resistant tremor have been previously described. [1][2][3][4] The onset is usually delayed (weeks to months/years), but they may also begin rapidly (within hours). Careful neuroradiologic examination may reveal small lesions, often in the deep brain a

Risperidone in the treatment of dopamine
Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial
โœ Erich Mohr; Tilak Mendis; Kathleen Hildebrand; Peter Paul De Deyn ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 78 KB ๐Ÿ‘ 1 views

## Purpose: To evaluate the safety and efficacy of risperidone in patients with parkinson's disease (pd) who are experiencing significant dopamine-induced psychosis. ## Patients and methods: Seventeen patients (median age, 72 yrs) participated in this 12-week, open pilot study receiving 0.5 to 3